These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 19810169

  • 1. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
    Clarke AM, Zemcov SJ.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():57-62. PubMed ID: 19810169
    [Abstract] [Full Text] [Related]

  • 2. In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
    Wilkinson LD, Gentry LO.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():53-6. PubMed ID: 19802969
    [Abstract] [Full Text] [Related]

  • 3. Ceftazidime: comparative in-vitro study.
    Verbist L, Verhaegen J.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
    [Abstract] [Full Text] [Related]

  • 4. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC.
    Scand J Infect Dis Suppl; 1993 Sep; 91():25-32. PubMed ID: 8290900
    [Abstract] [Full Text] [Related]

  • 5. In-vitro studies with ceftazidime against aerobic gram-negative bacilli and Bacteroides fragilis group.
    Acuna G, Johnston J, Young LS, Martin WJ.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():83-9. PubMed ID: 19810170
    [Abstract] [Full Text] [Related]

  • 6. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 7. The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.
    Vanhoof R, Gordts B, Coignau H, Stas G, Butzler JP.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():63-6. PubMed ID: 19802970
    [Abstract] [Full Text] [Related]

  • 8. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
    van Klingeren B.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
    [Abstract] [Full Text] [Related]

  • 9. In-vitro studies with ceftazidime.
    Giamarellou H, Avlami A, Matsakas V, Kosmidis J, Daikos GK.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():73-7. PubMed ID: 19802972
    [Abstract] [Full Text] [Related]

  • 10. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I, Warren C, Shannon K, King A, Hanslo D.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [Abstract] [Full Text] [Related]

  • 11. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P, Ryan DM, Sowa MA, Watts CM.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
    Giamarellou H, Sahin A, Chryssouli Z.
    Drugs Exp Clin Res; 1987 Sep; 13(3):149-53. PubMed ID: 3622243
    [Abstract] [Full Text] [Related]

  • 13. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
    Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN.
    Int J Antimicrob Agents; 2015 Jul; 46(1):53-9. PubMed ID: 25956844
    [Abstract] [Full Text] [Related]

  • 14. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [Abstract] [Full Text] [Related]

  • 15. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM, Zemcov SJ.
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
    [Abstract] [Full Text] [Related]

  • 16. The in-vitro activity of ceftazidime against clinically important pathogens.
    Knothe H, Dette GA.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():33-41. PubMed ID: 19810167
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983 Sep; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 18. An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
    Varotto F, Maria GD, Azzaro R, Bellissima P, Amato R, Fogliani V, Muscianisi G, Vitale S, Girbino G, Andò F, Laganà P, Delia S, Jacoviello C, Maierna G, Pezza A, Covelli I, Magrì M, Napoletano G, Rossi A, Marone P, Sanguinetti C, Pela R, Tedeschi D, Viola B, Cicciarella S, Messina G, Rizza S, Fraschini F.
    J Chemother; 2001 Aug; 13(4):413-23. PubMed ID: 11589485
    [Abstract] [Full Text] [Related]

  • 19. In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms.
    Jamieson CE, Lambert PA, Simpson IN.
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2615-8. PubMed ID: 12878527
    [Abstract] [Full Text] [Related]

  • 20. The in-vitro activity of ceftazidime compared with that of other cephalosporins.
    Bint AJ, Yeoman P, Kilburn P, Anderson R, Stansfield E.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():47-51. PubMed ID: 19802968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.